FBLGFibroBiologics, Inc.

Nasdaq fibrobiologics.com


$ 7.01 $ -0.07 (-0.97 %)    

Friday, 14-Jun-2024 15:59:42 EDT
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 7.11
$ 7.34
$ 6.63 x 100
$ 0.00 x 0
$ 6.71 - $ 7.75
$ 6.42 - $ 55.00
123,251
na
221.36M
$ -2.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases

Core News & Articles

- SEC Filing

Core News & Articles

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Core News & Articles

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued ...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

Core News & Articles

In the study using an imiquimod (IMQ)-induced psoriasis model in C57BL/6J mice, a single intravenous administration of HDF sphe...